Nuvalent Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Nuvalent Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Nuvalent Inc - Ordinary Shares - Class A
Rating: 1.42708325
Author: Trendlyne DVM scores

about

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that ...

80.93 -1.14 (-1.39%)

28.70% Fall from 52W High

373.4K

XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

3.8 / 100

Technically Neutral

53.3 / 100

No estimates available

Nuvalent Inc - Ordinary Sh... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nuvalent Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that ...

28.70% Fall from 52W High

SWOT Analysis

Nuvalent Inc - Ordinary Sh... Live Price Chart